Skip to main content
NVS logo
NVS
(NYSE)
Novartis AG
$146.42-- (--)
Loading... - Market loading

Novartis (NVS) Stock Price & Financial Analysis

Novartis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$146.39 - $148.53
52-Week High$170.46
52-Week Low$112.34
Open$147.54
Volume2.56M
Average Volume (3M)1.53M
Market Cap285.79B
Shares Outstanding1.92B
P/E Ratio (TTM)21.12
Forward P/E19.90
Price to Sales (P/S)5.05
Price to Book (P/B)7.42
EV/EBITDA14.47
Revenue (TTM)56.58B
Net Income (TTM)13.53B
Free Cash Flow (TTM)16.60B
EPS (TTM)$6.99
Profit Margin23.92%
Operating Margin30.43%
Return on Equity (ROE)35.14%
Debt to Equity1.17
50-Day MA$149.22
200-Day MA$141.28
52-Week Change24.06%
Annual Dividend$4.77
Dividend Yield3.26%
Payout Ratio68.29%
Last Dividend Ex-DateMar 11, 2026

Frequently Asked Questions About Novartis

What is the current stock price for NVS?

As of the latest trading session, NVS stock trades at $146.42. The 52-week range is $112.34–$170.46, with a day range of $146.39–$148.53.

What is the P/E ratio for NVS?

Novartis's trailing P/E ratio is 21.1, meaning investors pay $21.1 for every $1 of annual earnings. The forward P/E is 19.9, reflecting analyst expectations for future earnings. Novartis operates in the Healthcare sector.

Does NVS pay dividends?

Yes, Novartis pays a 3.26% annual dividend yield ($4.77 per share). The payout ratio is 68.3%. The last ex-dividend date was 2026-03-11.

What do analysts recommend for NVS?

Based on 1 analyst, the consensus for NVS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NVS?

Novartis's market capitalization is $280.54B, classifying it as a mega-cap company. Novartis operates in the Healthcare sector within the Drug Manufacturers - General industry.